Ascendis Pharma (ASND) PT Raised to $300 at Cantor Fitzgerald
Tweet Send to a Friend
(Updated - February 12, 2026 1:54 PM EST)
Cantor Fitzgerald analyst Li Watsek raised the price target on Ascendis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Li Watsek raised the price target on Ascendis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
